The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to venetoclax-containing regimens in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL).
 
Miles Thomas
No Relationships to Disclose
 
Apoorva Ravichandran
No Relationships to Disclose
 
Emily Dworkin
Honoraria - Abbvie
 
Caner Saygin
No Relationships to Disclose
 
Adam DuVall
Speakers' Bureau - CE Concepts
 
Wendy Stock
Honoraria - Adaptive Biotechnologies; Newave Pharmaceutical; servier
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Kura Oncology; Newave Pharmaceutical; Pfizer; SERVIER
Research Funding - Kura Oncology
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Anand Patel
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Cycle Pharma; Geron; Jazz Pharmaceuticals; Novartis; SOBI; Syndax
Research Funding - Incyte (Inst); Pfizer (Inst); SERVIER (Inst); Sumitomo Dainippon Pharma Oncology (Inst)